USPTO 2015–2025 USPTO PatentsView Foreign Corporation

Bausch + Lomb Ireland Limited

USPTO PatentsView assignee record - 27 granted patents across 26 technology areas, recorded in grant years 2023–2025. Grant-trend analysis is cross-referenced to USPTO Patent Public Search; it does not measure application filings, current R&D, or legal strength. Primary class: A61F (Filters Implantable Into Blood VESSELS; PROSTHESES; Devices Providing Patency TO, OR Preventing Collapsing OF, Tubular Structures OF THE Body, e.g. STENTS; Orthopaedic, Nursing OR Contraceptive Device).

RSS updates for this company

The verdict

According to USPTO PatentsView, Bausch ranks #11,178 of 49,997 tracked US assignees by granted-patent volume, with 27 patents across 26 technology areas.

#11,178
of 49,997 US assignees by volume
Top 3%
by Innovation Score (60.3/100)
18.0
avg claims per patent

USPTO PatentsView assignee plate

Corpus R11178 · Foreign Corporation #11,178 · 27 grants

GRANTS-SMALL · UPPER-Q · PHOTO-FINISH · CPC-FOCUS · INNOV-STRONG · CLAIMS-RICH · TYPE-FRNCORP · SPAN-YRS · BOOK-RICH

  • GRANTS-SMALL 27 grants
  • UPPER-Q #11,178/49,997
  • PHOTO-FINISH Belanger
  • CPC-FOCUS A61F · 26 areas
  • INNOV-STRONG 60.3/100
  • CLAIMS-RICH 18.0 claims/avg
  • TYPE-FRNCORP Foreign Corp
  • SPAN-YRS 2023–2025 · 3y
  • BOOK-RICH 9/10 fields

Nearest grant-volume peer: Belanger, Inc. (±0 grants)

Instrument codes from this assignee’s USPTO PatentsView grant sheet: volume band, corpus rank, photo-finish peer, lead CPC, Innovation Score, claim depth, assignee type, velocity, and book completeness. Not a USPTO rating of patent strength.

How Bausch’s 60.3 Innovation Score adds up

The same four weighted components behind every Innovation Score on PlainPatent: portfolio volume, grant velocity, technology breadth, and claim depth.

Innovation-score neighbourhood around Bausch

Lowest and highest poles plus nearest Innovation Score peers, not a full corpus board reprint.

score

What this shows Bausch's Innovation Score is 60.3/100 (top 3% of the PatentsView-derived corpus). The chart places that score against the nearest Innovation Score peers plus corpus poles, not a reprint of the volume ranking.

Source USPTO PatentsView, PlainPatent Innovation Score As of 2015–2025

Does more volume mean deeper claims for Bausch?

Each dot is one of Bausch’s 8 nearest volume peers (same corpus rank neighbourhood as the chart above), placed by total granted patents (horizontal) against average claims per patent (vertical). Bausch’s own 18.0 claims/patent is at or below the 18.7 median for these volume peers. Volume here does not track with deeper claims; several lower-volume peers claim more thoroughly per patent.

Bausch vs its 8 nearest volume peers: granted patents vs average claims per patent. Source: USPTO PatentsView. 2×2 strategic matrix plotting 9 entities by Granted patents (volume) (X) and Avg claims / patent (Y), with a crosshair dividing the plot into four quadrants. Volume + depthSelective & thoroughVolume over depthLean filer 26.92727.1 010203040 Granted patents (volume) Avg claims / patent Bonutti Research, Inc. - 27, 15.19Bonutti ResearchBTL Medical Technologies s.r.o. - 27, 28.52BTL Medical s r oBuccellati Holding Italia S.P.A. - 27, 1Buccellati Holdin…Bwxt Nuclear Energy, Inc. - 27, 20.3Bwxt Nuclear Ener…Belanger, Inc. - 27, 18.67BelangerBicycleTx Limited - 27, 21.59BicycletxBiohaven Therapeutics Ltd. - 27, 10.15Biohaven Therapeu…Black Diamond Oilfield Rentals LLC - 27, 35.33Black Diamond Oil…Bausch + Lomb Ireland Limited - 27, 18Bausch + Lomb Ire…
Bausch vs its 8 nearest volume peers: granted patents vs average claims per patent. Source: USPTO PatentsView.

Where Bausch's grants concentrate

Bausch + Lomb Ireland Limited is a focused PatentsView assignee: 26 CPC subclasses with 44.4% of grants classified under A61F (Filters Implantable Into Blood VESSELS; PROSTHESES; Devices Providing Patency TO, OR Preventing Collapsing OF, Tubular Structures OF THE Body, e.g. STENTS; Orthopaedic, Nursing OR Contraceptive Device). Peak complete grant year is 2024 (12 grants) versus a trough of 3 in 2023. By volume, Bausch sits between Bonutti Research, Inc. and Black Diamond Oilfield Rentals LLC.

Bausch's three-year grant acceleration

Bausch + Lomb Ireland Limited shows 15 grants in 2022–2024 against only 0 in 2019–2021. That prior window is too thin for a growth multiple (rename and spin-out assignees look artificially high when the baseline is near zero), so PlainPatent withholds a ranked acceleration claim here.

Who files at Bausch's volume?

Granted US patents 2015–2025 versus its nearest-ranked assignees by volume, this company marked ◀

patents

What this shows Bausch holds 27 patents at rank #11,186, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.

Source USPTO PatentsView, granted utility patents As of 2015–2025

Companies ranked near Bausch

By rank, the assignees closest to #11,186 in granted patent volume.

Leaders in A61F (Filters Implantable Into Blood Vessels)

Other assignees with the most granted patents in Bausch's primary technology class.

Assignees with similar portfolio profiles

Two PlainPatent-derived peer sets for Bausch, neither rank-band nor same-CPC leaders (those blocks stay above). In A61F (Filters Implantable Into Blood Vessels), Bausch ranks #539 of 3,082 assignees by patent count in that subclass.

Bausch's Innovation Score vs. every tracked assignee

Composite of portfolio volume, grant velocity, technology breadth, and claim depth (0–100)

60 Top 3% higher than 97% of 49,997 US assignees

This assignee 0 100 every tracked assignee, bucketed by value

Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025

2468101214 202320242025 12
USPTO utility patent grants by year · 2023–2025

Grants by year

Teal-shaded recent years (2020–present) versus the 2023–2019 baseline. Full figures in the table below.

View data table
Bausch + Lomb Ireland Limited patent grants by year, 2015–2025
Year Patents Granted Share of Period
2023 3 11.1%
2024 12 44.4%
2025partial year 12 44.4%

Which technologies does Bausch + Lomb Ireland Limited patent most?

Top 15 of 26 technology areas

More on this record

Data Source

USPTO PatentsView, US granted patents 2015–2025

What to do with this data

Bausch + Lomb Ireland Limited's patent record in context - here's where to go next.

  • Bausch + Lomb Ireland Limited's lead technology class is A61F (Filters Implantable Into Blood VESSELS; PROSTHESES; Devices Providing Patency TO, OR Preventing Collapsing OF, Tubular Structures OF THE Body, e.g. STENTS; Orthopaedic, Nursing OR Contraceptive Device), 44.4% of its portfolio - see every assignee active in that class. Explore A61F
  • Ranked #11,178 of 49,997 tracked assignees by patent volume - see the full leaderboard. See the ranking
  • Compare Bausch + Lomb Ireland Limited against Bonutti Research, Inc., an assignee filing at a similar volume. Compare portfolios
  • Innovation Score of 60.3/100 blends volume, velocity, technology breadth, and claim depth. How it's calculated

Figures reflect USPTO PatentsView grant data through May 2026; pending applications not yet granted are not counted.

Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.